Skip to main content
. 2018 Oct 16;2(20):2658–2671. doi: 10.1182/bloodadvances.2018021469

Figure 3.

Figure 3.

Kaplan-Meier curves for univariate analysis, irrespective of treatment approach. Stratified by (A) JAK2/MPL vs CALR vs triple-negative patients, (B) cytogenetic abnormalities, (C) TP53 mutation, and (D) number of mutations.